Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient.
Céline
C
Moreau
Dominique
D
Debray
Marie-Anne
MA
Loriot
Anne Marie
AM
Taburet
Valérie
V
Furlan
D000293:Adolescent; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics; D004347:Drug Interactions / Q000235:genetics; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics; D016031:Liver Transplantation; D008297:Male; D009853:Omeprazole / Q000008:administration & dosage / Q000627:therapeutic use*; D016559:Tacrolimus / Q000008:administration & dosage / Q000097:blood*
D000897:Anti-Ulcer Agents; D065607:Cytochrome P-450 Enzyme Inhibitors; D007166:Immunosuppressive Agents; D003577:Cytochrome P-450 Enzyme System; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; D009853:Omeprazole; D016559:Tacrolimus